Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 25 projects and 0 programmes
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Building a reproducible single-cell experimental workflow to capture tumour drug persistence
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification